Phyllis McKiernan on Blood and Marrow Transplants and Targeted Therapies
Phyllis McKiernan, MSN, APN, OCN, nurse practitioner, John Theurer Cancer Center at Hackensack University Medical Center, discusses blood and marrow transplantation and treating chronic myeloid leukemia (CML) with targeted therapies.
Phyllis McKiernan, MSN, APN, OCN, nurse practitioner, John Theurer Cancer Center at Hackensack University Medical Center, discusses blood and marrow transplantation and treating chronic myeloid leukemia (CML) with targeted therapies.
McKiernan says that many advances have been made in blood and marrow transplantation over the past 20 years and patients now can survive for a long time following a transplant.
Targeted therapy is one advancement that has been made in treating blood cancers, McKiernan says. These therapies target molecular mutations that are particular to a cancer and have less of an effect on normal cells.
Shared Model of Care Post-HCT Offers Safe Follow-Up, Reduces Patient Burden
Published: March 19th 2025 | Updated: March 19th 2025Alternating post-HCT care between specialized facilities and local cancer centers produced noninferior non-relapse mortality and similar quality of life to usual care.
